Pharmacokinetics of gabapentin in horses.
نویسندگان
چکیده
*Department of Veterinary Biosciences, University of Illinois, College of Veterinary Medicine, Urbana, IL; Department of Biomedical Sciences, College of Veterinary Medicine, Nursing and Allied Health, Tuskegee University, Tuskegee, AL; Livestock Disease and Diagnostic Center, College of Agriculture, University of Kentucky, Lexington, KY; Department of Large Animal Clinics, College of Veterinary Medicine, Nursing and Allied Health, Tuskegee University, Tuskegee, AL; 128C Maxwell Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY, USA
منابع مشابه
Pharmacokinetic profile and behavioral effects of gabapentin in the horse.
Gabapentin is being used in horses although its pharmacokinetic (PK) profile, pharmacodynamic (PD) effects and safety in the equine are not fully investigated. Therefore, we characterized PKs and cardiovascular and behavioral effects of gabapentin in horses. Gabapentin (20 mg/kg) was administered i.v. or p.o. to six horses using a randomized crossover design. Plasma gabapentin concentrations we...
متن کاملA comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.
Pregabalin and gabapentin share a similar mechanism of action, inhibiting calcium influx and subsequent release of excitatory neurotransmitters; however, the compounds differ in their pharmacokinetic and pharmacodynamic characteristics. Gabapentin is absorbed slowly after oral administration, with maximum plasma concentrations attained within 3-4 hours. Orally administered gabapentin exhibits s...
متن کاملImpact of concomitant antacid administration on gabapentin plasma exposure and oral bioavailability in healthy adult subjects.
The aim of this open-label, randomized, and 3-period crossover study was to evaluate the influences of concomitant antacid administration on the plasma disposition, intestinal absorption, and urinary excretion of gabapentin in humans. Gabapentin (200 mg) was orally administered alone, with 1 g magnesium oxide (MgO), or with 20 mg omeprazole to 13 healthy adult subjects. Oral bioavailability (BA...
متن کاملReview of the Treatment of Restless Legs Syndrome: Focus on Gabapentin Enacarbil
The FDA approved gabapentin enacarbil in 2011 as the first non-dopaminergic agent for the treatment of restless legs syndrome (RLS) symptoms. Although gabapentin enacarbil is a pro-drug of gabapentin, its pharmacokinetics differ. Absorption of gabapentin enacarbil is more predictable, and inter-patient variability in bioavailability is lower than that of gabapentin. Studies have demonstrated su...
متن کاملGabapentin enacarbil – clinical efficacy in restless legs syndrome
Restless legs syndrome (RLS) is a sleep-related movement disorder commonly involving an unpleasant urge to move the limbs, typically the legs. Dopaminergic agents represent the first-line therapy for RLS; however, long-term use of such drugs results in worsening symptoms due to "augmentation" or other adverse events. Gabapentin, an analog of the inhibitory neurotransmitter gamma-aminobutyric ac...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of veterinary pharmacology and therapeutics
دوره 31 2 شماره
صفحات -
تاریخ انتشار 2008